Identification of a possible proteomic biomarker in Parkinson's disease: discovery and replication in blood, brain and cerebrospinal fluid.
Winchester L. et al, (2023), Brain Commun, 5
New insights into the genetic etiology of Alzheimer's disease and related dementias.
Bellenguez C. et al, (2022), Nat Genet, 54, 412 - 436
Neurons derived from individual early Alzheimer's disease patients reflect their clinical vulnerability.
Ng B. et al, (2022), Brain Commun, 4
ANMerge: A comprehensive and accessible Alzheimer’s disease patient-level dataset
Birkenbihl C. et al, (2020)
Dysregulated Fc gamma receptor-mediated phagocytosis pathway in Alzheimer's disease: network-based gene expression analysis.
Park YH. et al, (2020), Neurobiol Aging, 88, 24 - 32
Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer’s disease: the MADE Phase II, three-arm RCT
Howard R. et al, (2020), Efficacy and Mechanism Evaluation, 7, 1 - 62
Tau pathology in early Alzheimer’s disease is linked to selective disruptions in neurophysiological network dynamics
Kocagoncu E. et al, (2020), Neurobiology of Aging
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.
Westwood S. et al, (2020), J Alzheimers Dis, 74, 213 - 225
Will We Have a Drug for Alzheimer's Disease by 2030? The View From Pharma.
Lovestone S. and Manji HK., (2020), Clin Pharmacol Ther, 107, 79 - 81
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial.
Howard R. et al, (2019), JAMA Neurol
A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease.
Ashton NJ. et al, (2019), Sci Adv, 5
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study.
Ten Kate M. et al, (2018), Alzheimers Res Ther, 10
Cross-sectional and longitudinal analyses of outdoor air pollution exposure and cognitive function in UK Biobank.
Cullen B. et al, (2018), Sci Rep, 8
Heterogeneous patterns of brain atrophy in Alzheimer's disease.
Poulakis K. et al, (2018), Neurobiol Aging, 65, 98 - 108
Elevated DNA methylation across a 48-kb region spanning the HOXA gene cluster is associated with Alzheimer's disease neuropathology.
Smith RG. et al, (2018), Alzheimers Dement
Imaging Aβ and tau in early stage Alzheimer's disease with [18F]AV45 and [18F]AV1451.
Firouzian A. et al, (2018), EJNMMI Res, 8
Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection.
Pardiñas AF. et al, (2018), Nat Genet, 50, 381 - 389